Bank of Montreal
TEVA icon

Bank of Montreal’s Teva Pharmaceuticals TEVA Stock Holding History

Bank of Montreal’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.9M Buy
971,583
+92,238
+10% +$3.07M 0.01% 733
2026
Q1 		$26.5M Sell
879,345
-358,721
-29% -$11.5M 0.01% 747
2025
Q4 		$38.6M Buy
1,238,066
+405,122
+49% +$9.98M 0.01% 646
2025
Q3 		$16.8M Buy
832,944
+357,007
+75% +$6.27M 0.01% 846
2025
Q2 		$7.98M Buy
475,937
+65,191
+16% +$1.05M ﹤0.01% 1079
2025
Q1 		$6.31M Buy
410,746
+2,524
+0.6% +$45.1K ﹤0.01% 1094
2024
Q4 		$9M Buy
408,222
+207
+0.1% +$3.77K ﹤0.01% 1030
2024
Q3 		$7.12M Sell
408,015
-5,744
-1% -$101K ﹤0.01% 1175
2024
Q2 		$6.83M Buy
413,759
+59,648
+17% +$919K ﹤0.01% 1148
2024
Q1 		$5.13M Sell
354,111
-2,605
-0.7% -$32.8K ﹤0.01% 1215
2023
Q4 		$3.74M Buy
356,716
+32
+0% +$299 ﹤0.01% 1391
2023
Q3 		$3.78M Sell
356,684
-3,357
-0.9% -$31.3K ﹤0.01% 1390
2023
Q2 		$2.89M Sell
360,041
-7,376
-2% -$59.8K ﹤0.01% 1613
2023
Q1 		$3.26M Sell
367,417
-116,767
-24% -$1.15M ﹤0.01% 1434
2022
Q4 		$4.52M Sell
484,184
-1,953,106
-80% -$17M ﹤0.01% 1345
2022
Q3 		$19.9M Buy
2,437,290
+741,591
+44% +$6.56M 0.01% 692
2022
Q2 		$14.1M Sell
1,695,699
-2,115,648
-56% -$18.4M 0.01% 907
2022
Q1 		$35.8M Buy
3,811,347
+1,787,830
+88% +$14.9M 0.02% 576
2021
Q4 		$16M Sell
2,023,517
-751,349
-27% -$6.78M 0.01% 812
2021
Q3 		$27.7M Sell
2,774,866
-687,510
-20% -$6.44M 0.01% 780
2021
Q2 		$35.5M Buy
3,462,376
+3,205,928
+1,250% +$33.9M 0.02% 638
2021
Q1 		$2.82M Sell
256,448
-808
-0.3% -$9.27K ﹤0.01% 1616
2020
Q4 		$2.93M Sell
257,256
-111,638
-30% -$1.07M ﹤0.01% 1646
2020
Q3 		$3.39M Buy
368,894
+1,274
+0.3% +$13.5K ﹤0.01% 1419
2020
Q2 		$4.27M Buy
367,620
+120,335
+49% +$1.36M ﹤0.01% 1236
2020
Q1 		$2.01M Sell
247,285
-111,269
-31% -$1.14M ﹤0.01% 1422
2019
Q4 		$3.52M Buy
358,554
+89,122
+33% +$796K ﹤0.01% 1561
2019
Q3 		$1.85M Buy
269,432
+50,881
+23% +$390K ﹤0.01% 1739
2019
Q2 		$2.02M Sell
218,551
-351,508
-62% -$4.24M ﹤0.01% 1690
2019
Q1 		$8.94M Buy
570,059
+38,659
+7% +$682K 0.01% 892
2018
Q4 		$8.19M Sell
531,400
-217,262
-29% -$4.45M 0.01% 853
2018
Q3 		$16.1M Buy
748,662
+185,609
+33% +$4.31M 0.01% 735
2018
Q2 		$13.7M Buy
563,053
+28,678
+5% +$585K 0.01% 764
2018
Q1 		$9.13M Sell
534,375
-629
-0.1% -$12.3K 0.01% 888
2017
Q4 		$10.1M Sell
535,004
-119,898
-18% -$1.8M 0.01% 858
2017
Q3 		$11.5M Buy
654,902
+25,365
+4% +$571K 0.01% 795
2017
Q2 		$20.9M Sell
629,537
-8,889
-1% -$275K 0.02% 574
2017
Q1 		$20.5M Buy
638,426
+42,960
+7% +$1.47M 0.02% 555
2016
Q4 		$22.4M Buy
595,466
+182,555
+44% +$7.29M 0.02% 510
2016
Q3 		$19M Buy
412,911
+38,461
+10% +$2.01M 0.02% 568
2016
Q2 		$18.8M Buy
374,450
+59,047
+19% +$3.14M 0.02% 564
2016
Q1 		$16.9M Sell
315,403
-33,858
-10% -$1.99M 0.02% 559
2015
Q4 		$22.9M Buy
349,261
+9,945
+3% +$615K 0.03% 434
2015
Q3 		$19.2M Sell
339,316
-1,095,406
-76% -$71M 0.03% 467
2015
Q2 		$84.8M Sell
1,434,722
-61,966
-4% -$3.82M 0.1% 189
2015
Q1 		$93.2M Buy
1,496,688
+1,117,751
+295% +$65M 0.11% 179
2014
Q4 		$21.8M Sell
378,937
-8,739
-2% -$487K 0.02% 447
2014
Q3 		$20.8M Sell
387,676
-110,503
-22% -$5.85M 0.02% 481
2014
Q2 		$26.1M Buy
498,179
+360,677
+262% +$18.4M 0.03% 404
2014
Q1 		$7.27M Sell
137,502
-23,325
-15% -$1.08M 0.01% 791
2013
Q4 		$6.45M Sell
160,827
-61,637
-28% -$2.43M 0.01% 747
2013
Q3 		$8.4M Sell
222,464
-15,372
-6% -$600K 0.01% 568
2013
Q2 		$9.32M Buy
+237,836
New +$9.26M 0.02% 513

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bank of Montreal's TEVA Position: Q2 2026 in Review

Bank of Montreal increased its Teva Pharmaceuticals (TEVA) stake by 10% in Q2 2026, buying an estimated $3.07M and bringing the position to 971,583 shares worth $32.9M. The position accounts for 0.01% of the portfolio, ranked #733.

Bank of Montreal first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $93.2M in Q1 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bank of Montreal held 971,583 shares of Teva Pharmaceuticals worth $32.9M as of Q2 2026.
  • Bank of Montreal bought 92,238 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.07M.
  • Teva Pharmaceuticals made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #733 holding.
  • Bank of Montreal first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Teva Pharmaceuticals position peaked at $93.2M in Q1 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.